| Newswire Search | Up to 90 Days | 56 stories | 39 Publishers |
| Topic | # Mentions | Topic Reach |
|---|---|---|
| novo nordisk | 36 | - |
| glp | 6 | - |
| Byline | Articles Written | Avg Reach |
|---|---|---|
| n/a | 28 | - |
| Michael Barrett | 2 | - |
| Annika Kim Constantino | 2 | - |
| Reuters | 2 | - |
| ABMN Staff | 2 | - |
| Alex Harring | 2 | - |
| Michael McAuliff | 1 | - |
| Elsa Ohlen | 1 | - |
| Liz Napolitano | 1 | - |
| JOSH FUNK | The Associated Press | 1 | - |
| ABC News | 1 | - |
| Associated Press | 1 | - |
| Eshita Gain | 1 | - |
| AFP AFP | 1 | - |
| Yeo Boon Ping | 1 | - |
| Christina Cheddar Berk,Liz Napolitano | 1 | - |
| The Associated Press | 1 | - |
| Julie Coleman | 1 | - |
| The Washington Post | 1 | - |
| Chris Williams | 1 | - |
Execution: 18.03 Seconds. 137.58 mb used.
Novo CEO blasts ‘mass compounding’ of GLP-1 drugs as safety battle escalates
Novo Nordisk Files Patent Infringement Suit Involving Compounded Semaglutide Products
FDA says Novo Nordisk's TV ad for obesity pill includes 'false or misleading' claims
Stocks making the biggest moves premarket: Oracle, Novo Nordisk, Hims & Hers Health, Kroger and more
Hims & Hers drops plan for knockoff of Novo Nordisk's new Wegovy weight loss pill